PET-CT FDG: 700 USD
PET-CT Ga68 PSMA: 1700 USD
Full-Body MRI (3 Tesla): 900 USD
Stereotactic Radiosurgery (SRS): 4500 USD
Radiotherapy Treatment (Starts from): 4000 USD
Radioactive Iodine Therapy (Starts from): 3500 USD
Check-up (Starts from): 900 USD
Lu-177 PSMA Therapy: 9000 USD
Ac-225 PSMA Therapy (Starts from): 16000 USD
Brain Surgery (Starts from): 15000 USD
Breast Cancer Surgery (Starts from): 8000 USD
MIBG Scan (Starts from): 2500 USD
PET-CT FDG: 700 USD
PET-CT Ga68 PSMA: 1700 USD
Full-Body MRI (3 Tesla): 900 USD
Stereotactic Radiosurgery (SRS): 4500 USD
Radiotherapy Treatment (Starts from): 4000 USD
Radioactive Iodine Therapy (Starts from): 3500 USD
Check-up (Starts from): 900 USD
Lu-177 PSMA Therapy: 9000 USD
Ac-225 PSMA Therapy (Starts from): 16000 USD
Brain Surgery (Starts from): 15000 USD
Breast Cancer Surgery (Starts from): 8000 USD
MIBG Scan (Starts from): 2500 USD
The term “remission” in relation to cancer has evolved over time, reflecting advancements in medical understanding and treatment approaches. Historically, cancer was considered an untreatable condition, and any temporary relief from symptoms was often seen as a rare, miraculous event rather than a scientifically explainable phase of the disease.
By the early 20th century, as radiation therapy and chemotherapy became more structured treatments, doctors began to observe cases where cancer symptoms disappeared or tumors shrank significantly without entirely eradicating the disease. These cases led to the formal introduction of “remission” as a recognized medical term.
Over time, researchers and oncologists refined the term, categorizing it into partial remission and complete remission—a distinction that continues to shape how treatment success is measured today.
Cancer remission refers to a period when the signs and symptoms of cancer are reduced or completely undetectable. It does not always mean that cancer is entirely gone, but it does indicate a significant improvement in the patient’s condition.
There are two main types of remission:
Consider the case of Sarah, a 45-year-old breast cancer patient diagnosed with stage II cancer. After undergoing chemotherapy and targeted therapy, her tumor reduced in size significantly, leading to partial remission. With continued treatment and monitoring, she later achieved complete remission, meaning no active cancer was detectable in her body. However, her doctors emphasized regular follow-ups to monitor any potential recurrence.
Understanding remission is crucial, but it is also essential to recognize other related terms:
The duration of remission varies widely depending on the type of cancer, treatment effectiveness, and the patient’s overall health. Some individuals remain in remission for months, years, or even a lifetime, while others may experience a relapse requiring additional treatment.
Doctors generally use a five-year benchmark to assess long-term remission. If no signs of cancer appear for five years after treatment, some cancers are considered unlikely to return. However, continuous monitoring and healthy lifestyle choices remain crucial.
For individuals in remission, adopting a proactive approach to health is essential:
The future of cancer remission looks promising with the development of personalized medicine, immunotherapy, and precision oncology. These innovative approaches focus on targeting cancer at a molecular level, improving remission rates, and potentially leading to more permanent cures.
With ongoing research and cutting-edge treatments, more cancer patients are achieving long-term remission, offering hope for a future where cancer survival rates continue to improve.
WhatsApp us